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The O’Neill Institute for National and Global Health Law at Georgetown University is the
premier center for health law, scholarship and policy. Housed at Georgetown University Law
Center, in the heart of the nation’s capital, the Institute has the mission to provide innovative
solutions for the leading health problems in America and globally—from infectious and chronic
diseases to health care financing and health systems. The Institute, a joint project of the Law
Center and School of Nursing and Health Studies, also draws upon the University’s considerable
intellectual resources, including the School of Medicine, the Public Policy Institute, and the
Kennedy Institute of Ethics.
The essential vision for the O’Neill Institute rests upon the proposition that the law has
been, and will remain, a fundamental tool for solving critical health problems in our global,
national, and local communities. By contributing to a more powerful and deeper
understanding of the multiple ways in which law can be used to improve health, the O’Neill
Institute hopes to advance scholarship, research, and teaching that will encourage key decisionmakers in the public, private, and civil society sectors to employ the law as a positive tool for
enabling more people in the United States and throughout the world to lead healthier lives.


Teaching. Georgetown is educating future generations of students who will become – upon
their graduation – policymakers, health professionals, business leaders, scholars, attorneys,
physicians, nurses, scientists, diplomats, judges, chief executive officers, and leaders in many
other private, public, and nonprofit fields of endeavor. The O’Neill Institute helps to prepare
graduates to engage in multidisciplinary conversations about national and global health care
law and policy and to rigorously analyze the theoretical, philosophical, political, cultural,
economic, scientific, and ethical bases for understanding and addressing health problems.



Scholarship. O’Neill supports world-class research that is applied to urgent health problems,
using a complex, comprehensive, interdisciplinary, and transnational approach to go beyond
a narrow vision of health law that focuses solely on health care as an industry or as a
scientific endeavor.



Reflective Problem-Solving. For select high-priority issues, the O’Neill Institute organizes
reflective problem-solving initiatives in which the Institute seeks to bridge the gap between
key policymakers in the public, private, and civil society sectors and the intellectual talent
and knowledge that resides in academia.
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OVERVIEW
LEGAL SOLUTIONS IN HEALTH REFORM
The American public has increasingly identified health care as a key issue of concern. In order
to address the multiple problems relating to the access and affordability of health care, President
Obama and federal lawmakers across the political spectrum continue to call for major health
reform. In any debate on health reform, a predictable set of complex policy, management,
economic, and legal issues is likely to be raised. Due to the diverse interests involved, these
issues could lead to a series of high-stakes policy debates. Therefore, it is critical that
advocates of reform strategies anticipate such issues in order to decrease the likelihood that
legally resolvable questions become barriers to substantive health reform. In an effort to
frame and study legal challenges and solutions in advance of the heat of political debate, the
O’Neill Institute for National and Global Health Law at Georgetown University and the Robert
Wood Johnson Foundation have crafted the “Legal Solutions in Health Reform” project.
This project aims to identify practical, workable solutions to the kinds of legal issues that may
arise in any upcoming federal health reform debate. While other academic and research
organizations are exploring important policy, management, and economic questions relating to health
reform, the O’Neill Institute has focused solely on the critical legal issues relating to federal health
reform. The target audience includes elected officials and their staff, attorneys who work in key
executive and legislative branch agencies, private industry lawyers, academic institutions, and other
key players. This project attempts to pave the road towards improved health care for the nation
by providing stakeholders a concise analysis of the complex legal issues relating to health
reform, and a clear articulation of the range of solutions available.

LEGAL ISSUES V. POLICY ISSUES
Among the major issues in federal health reform, there are recurring questions that are policybased and those that are legally-based. Many times questions of policy and of law overlap and
cannot be considered in isolation. However, for the purpose of this project, we draw the
distinction between law and policy based on the presence of clear legal permission or
prohibition.
Under this distinction, policy issues include larger-scale questions such as what basic model of
health reform to use, as well as more technical questions such as what threshold to use for
poverty level subsidies and cost-sharing for preventive services. In contrast, legal issues are
those involving constitutional, statutory, or regulatory questions such as whether the Constitution
allows a certain congressional action or whether particular laws run parallel or conflict.
Based on this dividing line of clear permission or prohibition, policy questions can be framed as
those beginning with, “Should we…?”, and legal questions can be framed as those beginning
with, “Can we…?” The focus of this paper will be the latter, broken into three particular
categories: 1) “Under the Constitution, can we ever…?”; 2) “Under current statutes and
regulations, can we now…?”; 3) “ Under the current regulatory scheme, how do we…?” This
final set of questions tends to be mixed questions of policy, law, and good legislative drafting.
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PURPOSE AND LAYOUT OF THE PROJECT
This project is an effort to frame and study legal challenges and solutions in advance of the heat
of political debate. This effort is undertaken with the optimistic view that all legal problems
addressed are either soluble or avoidable. Rather than setting up roadblocks, this project is a
constructive activity, attempting to pave the road towards improved health care for the nation.
Consequently, it does not attempt to create consensus solutions for the identified problems nor is
it an attempt to provide a unified field theory of how to provide health insurance in America.
Furthermore, this project does not attempt to choose among the currently competing proposals or
make recommendations among them. Instead, it is a comprehensive project written to provide
policy makers, attorneys, and other key stakeholders with a concise analysis of the complex legal
issues relating to health reform and a clear articulation of the range of solutions available for
resolving those questions.

LEGAL ISSUES
Based on surveys of current health policy meetings and agendas, popular and professional press,
and current health reform proposals, our team formulated a list of legal issues relating to federal
health reform. After much research, discussion, and expert advice and review, our initial list of
over 50 legal issues was narrowed to ten. An initial framing paper was drafted which identified
these ten legal issues and briefly outlined the main components of each. In May of 2008, a
bipartisan consultation session was convened to provide concrete feedback on the choice and
framing of the legal issues. The attendees of the consultation session included congressional
staff, executive branch officials, advocates, attorneys, employers, and representatives of a wide
range of interests affected by health reform. Feedback and analysis from this session further
narrowed the ten issues to eight key legal issues which warranted in depth analysis of the current
law.
These eight pertinent issues are truly legal in nature and must be addressed in any significant
reform proposal to avoid needless debate or pitfalls as policy decisions are made. There are
multiple other legal issues that will arise as the discussion evolves and, if a federal policy is
adopted, the system changes. In this project, however, we have targeted the issues essential for
an immediate discussion of federal health reform.
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EXECUTIVE SUMMARY
Prepared by the O’Neill Institute

INTRODUCTION:
Within constitutional and statutory boundaries, the Obama Administration can use its executive
authority and administrative tools to reform health care incrementally without Congressional
approval. Under current law, the Administration can:
1)
2)
3)
4)
5)

promote its policy goals through demonstration projects;
increase the use of health information technology;
reduce drug costs;
increase coverage portability; and
expand SCHIP eligibility.

The Administration does not, however, have the unilateral power to establish a national health
insurance exchange, create a new small business health tax credit, or require employers to “payor-play.”
TOOLS OF THE PRESIDENTIAL ADMINISTRATION TO REFORM HEALTH CARE:
The Obama Administration has three primary tools to direct the actions of administrative
agencies: regulations, sub-regulatory guidance, and executive orders. Administrative agencies
promulgate regulations pursuant to Congressional delegations of authority in statutes. Subregulatory guidance implements policy within an executive agency and includes letters,
memoranda, determinations, agreements, findings, and other types of directives. Presidents
employ executive orders to direct the actions of agency employees and instruct them to create or
implement particular policies.
PROMOTE POLICY GOALS THROUGH DEMONSTRATION PROJECTS:
The Administration can pursue its policy goals through Medicaid, Medicare, and SCHIP
demonstration projects. Section 1115 of the Social Security Act (Act) gives the Secretary of
Health and Human Services (HHS) broad authority to waive certain Medicaid and SCHIP
requirements for states to test new ideas. Similarly, Section 222 of the Social Security
Amendments of 1972 gives the Secretary authority to develop demonstration projects to test
provider quality initiatives. For example, the Secretary could allow states to expand coverage for
low-income adults using Section 1115 waivers, or implement “pay-for-performance” for care
received under Medicare using Section 222 waivers.
INCREASE THE USE OF HEALTH INFORMATION TECHNOLOGY:
The new Administration can increase the use of health information technology (IT) through
several ways. President Obama can issue an executive order similar to Executive Order 13410,
which directed administrative agencies to complete a comprehensive review of the numerous
health IT programs currently underway and to coordinate the activities of various agencies.
Additionally, the Centers for Medicare & Medicaid Services (CMS) can promulgate regulations
to expand the scope of the physician reimbursement program. Finally, CMS can create more
demonstration projects similar to the Electronic Health Records Demonstration, which
reimburses physicians who adopt health IT and report performance data.
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REDUCE DRUG COSTS IN MEDICARE:
The Administration can reduce drug costs by creating a Medicare drug re-importation program
under section 1121 of the Medicare Modernization Act of 2003 (MMA). In addition, the
Secretary can lower costs by negotiating payments with Medicare Administrator Contractors
under its section 911 contracting authority. Because the MMA explicitly denies the
Administration the authority to negotiate Medicare Part D drug prices with manufacturers for
drugs, legislative amendments would be necessary to give the Secretary negotiating power.
ENHANCE PATIENT PROTECTIONS AND IMPROVE COVERAGE PORTABILITY:
There are two ways that the Administration can enhance patient protections and improve
coverage portability with fewer restrictions. First, the Administration can institute greater patient
protections in the Federal Employees Health Benefits Plan (FEHBP) to help policymakers better
understand these protections before enacting them for the insurance industry. Second, the
Administration can amend the Final Rule for the Health Insurance Portability and Accountability
Act (HIPAA) to improve coverage portability for individuals.
LIFT AGENCY DIRECTIVES THAT RESTRICT SCHIP AND MEDICAID:
The Administration can expand SCHIP and Medicaid eligibility by reconsidering current
regulations that restrict eligibility and cut funding. For example, President Obama issued a
Memorandum on February 4, 2009, requesting that the Secretary of the Department of Health
and Human Services immediately withdraw an August 17, 2007, letter -- which limits state
health officials’ discretion to set income eligibility caps for families whose children participate in
the children’s health insurance program -- and implement SCHIP without the requirements it
imposed.
BUILD ON FEHBP:
Numerous policymakers have proposed opening the Federal Employees Health Benefit Plan
(FEHBP) to the public or creating a similar program for Americans with pre-existing conditions.
The new Administration could memorialize many of FEHBP’s best practices through executive
orders or memoranda so that private insurers and the federal government can better understand
what policies work to reduce costs and ensure quality care. Making coverage available to
members of the public through the program, however, would require Congressional action.
POLICIES THAT REQUIRE LEGISLATIVE ENACTMENT:
Although the Administration has significant opportunities to invoke its executive authority, it can
only act within the bounds of a statute. There are numerous policy changes that would require
legislative enactment first. Any changes to the tax code or proposals to purchase insurance
across state lines, for example, would require legislative action.
CONCLUSION:
Although the President’s executive authority could allow him to begin implementing crucial
reforms, he also must pay careful attention to legal, budgetary, and legislative constraints on that
authority. The above policy recommendations are examples of ways that the new Administration
can take incremental steps toward health care reform. There are many opportunities for using the
President’s executive authority and administrative tools to lay the foundation for more expansive
health reform.
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Legal Solutions in Health Reform:
Executive Authority to Reform Health: Options and Limitations
Madhu Chugh 
Introduction
Presidential power has provoked increasingly vigorous debate since the turn of this century. In
recent years, scholars and lawyers have been grappling with how Congress’s dictates may limit
the President’s Commander-in-Chief power to detain enemy combatants at Guantanamo Bay, to
fight wars abroad, and to conduct intelligence activities at home. But policymakers have not yet
explored the many possibilities for invoking the President’s “Take Care” power to change health
care policy.
This paper explores the scope and limits of President Barack Obama’s ability to invoke his
executive authority to reform health care. Specifically, it identifies ways the Obama
Administration can use directives to: (1) expand Medicaid and SCHIP coverage through section
1115 waivers; (2) test quality initiatives through Medicare demonstration authority; (3) expand
health information technology; (4) allow drug reimportation and experiment with contracting
power under Medicare; (5) enhance patient protections and private coverage requirements; (6)
lift coverage restrictions on Medicaid and SCHIP; and (7) build on the health insurance program
for federal employees. Consistent with the mission of the Legal Solutions in Health Reform
project, this paper does not endorse a particular policy. Instead of recommending “what,” it
explains “how.”
Policymakers in the Obama Administration are not the only ones who need to understand the
scope of executive authority. As Congress begins to tackle its health care agenda, policymakers
on the Hill should know how proposed legislation would affect the President’s power. More
specific statutes would limit the executive branch’s ability to make policy decisions. On the
other hand, health reform legislation that provides only the skeleton of a new program would
provide greater opportunities for President Obama and his agencies to fill out the details. There
is ample precedent for this approach. For example, Congress opened the door for President
Roosevelt’s groundbreaking New Deal policies by authorizing the creation of new programs
while providing minimal guidance on key details of administrative implementation. 1 In addition,
legislators should keep in mind that how they draft legislation can affect the level of deference
that courts provide to agency interpretations of statutes. Fewer statutory details mean greater
judicial deference to the executive in the event of a challenge.
Part I provides a user’s manual on executive authority. With an eye toward the non-legal
audience, it describes the various administrative tools at the President’s disposal. Part II moves
the discussion from the conceptual to the specific. It suggests ways that President Obama could
use administrative tools to reform health care. While this paper focuses on the “how,” it borrows
the “what” from many existing health care proposals, including policies offered during the 2008
Presidential campaign by Barack Obama and John McCain. Part II ends by identifying a few
areas in which the President could not use administrative tools to make policy changes.
O’NEILL INSTITUTE FOR NATIONAL AND GLOBAL HEALTH LAW
GEORGETOWN LAW | 600 NEW JERSEY AVENUE NW | WASHINGTON, DC 20001
www.oneillinstitute.org
3

Part III assesses the potential legal, budgetary, and legislative constraints on a President’s Article
II powers to interpret the law. It explains how Congress and the courts can limit the President’s
latitude to make policy changes through the administrative process. More broadly, it highlights
the continuing struggle between the three branches to influence health policy. The paper
concludes with a discussion of why congressional lawmakers should consider how their
proposed legislation would impact executive authority as they craft health reform proposals.
I. Overview of Executive Authority
Decreasing health care costs, expanding coverage, modernizing the delivery of care—there are
an endless number of policy proposals for reforming our health care system. Policymakers in
Congress and in the Obama Administration are crafting the key reform proposals that will shape
their agenda. It is important to remember that the process through which these policies are
created can be just as critical to the overall success as getting the substance of the policy right.
Presidents have a wide array of administrative options at their disposal. This section briefly
describes these various tools and explains how executive authority has evolved during the past
thirty years.
Administrative law scholars deem the various tools at a President’s disposal as “presidential
directives.” There are numerous types of directives, but all share the general purpose of
“establishing new policy, decreeing the commencement or cessation of some action, or ordaining
that notice be given to some declaration.” 2 Directives can be divided into three categories:
executive orders and proclamations, regulatory actions, and sub-regulatory guidance. In
addition, Presidents use signing statements to communicate their disagreement with statutory
provisions they believe encroach on their executive authority. As explained in Part III, courts
scrutinize each type of administrative tool to varying degrees when reviewing the legality of
administrative action.
A. Executive Orders and Proclamations
Perhaps the most well-known directive is the executive order, which dates back to George
Washington’s Administration. Presidents employ executive orders to direct the actions of
agency employees and instruct subordinates to create or implement particular policies. 3 The
sources of authority for executive orders are twofold: one is constitutional, including the Article
II requirement that the President “take Care that the Laws be faithfully executed,” 4 and the other
is any statutory language that delegates specific power to the executive branch to implement and
flesh out the details of a duly enacted program. Executive orders can make significant policy
changes, particularly during wartime or when a President relies on his constitutional powers to
deal with an emergency situation. 5 For example, President Abraham Lincoln’s Emancipation
Proclamation consisted of two executive orders freeing slaves in most of the confederate states. 6
Proclamations, another type of presidential directive, differ from executive orders in that they are
generally aimed at the public rather than agencies. Modern-day proclamations generally
encourage activity or recognize interests rather than direct specific action. 7 Otherwise, most of
the differences between proclamations and executive orders are formal rather than substantive. 8
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Like executive orders, Presidents must publish all proclamations pursuant to the requirements of
the Federal Register Act of 1935. 9
B. Regulatory Actions
Regulations—also known as rules—are a common administrative tool invoked by agencies. The
Administrative Procedure Act (“APA”) defines them as “the whole or part of an agency
statement of general or particular applicability and future effect designed to implement, interpret,
or prescribe law or policy.” 10 Often, Congress will delegate authority to agencies to flesh out the
details of a new program by promulgating regulations. These rules not only must stay within the
bounds of the statutory language, they also must be consistent with the Constitution (like any
other directive). In addition, the APA requires agencies to notify the public before issuing a rule
so that interested parties can comment on the proposal. 11 There is a large body of literature
analyzing the various permutations of the regulatory process, as well as the legal weight afforded
to regulations. This Paper touches on these issues in Part III.
C. Sub-regulatory Guidance
Sub-regulatory guidance includes letters, memoranda, determinations, agreements, findings, and
other types of directives. 12 Agencies often use sub-regulatory guidance to implement
demonstration projects authorized by Congress, as explained in Part II. There is an open debate
about whether this includes forms of communication typically associated with public relations—
for example, press releases and web pages. Presidents and their agencies have employed subregulatory guidance to direct and govern the activities of federal employees, and, much like
executive orders and proclamations, they may have the force of law if published in the Federal
Register and issued pursuant to a valid source of executive authority. 13 The only difference
between sub-regulatory guidance and executive orders and proclamations is that there are no
mandatory publication requirements for sub-regulatory guidance unless 1) Congress has required
it or 2) the directives have “general applicability and legal effect.” 14
D. Signing Statements
Although not a presidential directive (partly because it does not establish policy), a signing
statement is another tool in the executive’s arsenal. When presidents sign bills into law, they
sometimes issue official pronouncements “to forward the President’s interpretation of the
statutory language; to assert constitutional objections to the provisions contained therein; and . . .
to announce that the provisions of the law will be administered in a manner that comports with
the Administration’s conception of the President’s constitutional prerogatives.” 15 Often,
Presidents use signing statements to communicate disagreement about statutory provisions that
they believe encroach on their executive authority. Even though Presidents technically began
using signing statements more than two hundred years ago, President Ronald Reagan was the
first to invoke them in voicing substantial constitutional concerns regarding statutory language. 16
It is unclear whether signing statements have the force of law. Many scholars argue that if a
President’s application of the statute conflicts with the wishes of Congress, signing statements do
not provide an authoritative source of power to rectify or even assuage an unlawful
interpretation. 17 No court of law, however, has answered this question.
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II. Legal Prescriptions for Policy Proposals
The economic crisis and growing federal deficit may limit the prospect of congressional action
on big-ticket items. Or, conversely, the dire economic situation might create an environment in
which “deficits don’t matter,” thereby enabling the President and Congress to propose significant
health reform legislation. No matter which congressional strategy the Obama Administration
embraces, there are numerous ways the President can rely on his executive authority to create
policies that help reshape federal programs and make improvements to the health care system. In
addition, President Obama can invoke various administrative tools to lay the groundwork for
future reform, much like Presidents Roosevelt, Truman, Kennedy, and Johnson did in the area of
civil rights. 18
This section suggests ways that President Obama could use executive power to make health care
policy without relying on Congress. The proposals below reflect some areas of common ground
between the health care proposals offered by President Barack Obama and Senator John McCain
during the presidential campaign, as well as the numerous legislative proposals currently being
considered. This paper neither endorses nor condemns any of the policies; rather, it simply
explains how the directives explained above may help the next President achieve some of his
goals. The section ends by identifying policy proposals that would require enactment of
legislation.
A. Expand Medicaid & SCHIP Coverage Through Section 1115 Waiver Authority
Nearly all of the current health reform proposals include some expansion of Medicaid and
SCHIP. President Obama has discussed changing eligibility requirements, while Senator
McCain suggested experimenting with Medicaid’s payment scheme to allow greater coordinated
care and alternative forms of access. Senators Ron Wyden and Robert Bennett have proposed
converting Medicaid and SCHIP into supplemental insurance programs that would “wrap
around” private coverage. 19 Senators Edward Kennedy and Max Baucus both have voiced
strong support for instituting a variety of mechanisms to increase the number of children and
adults covered.
One of the most significant sources of executive authority for testing these ideas on a large scale
is section 1115 of the Social Security Act. 20 Congress enacted this provision to allow states to
obtain waivers from the federal government to create demonstration projects that were limited in
scope and short-term in nature. But the evolution of section 1115 illustrates how President
Obama could use the waiver authority to allow significant flexibility in state Medicaid programs,
including coverage expansions.
Section 1115 provides broad and general authority to the Secretary of the Department of Health
and Human Services (HHS) to waive statutory and regulatory provisions without congressional
approval or public notice. The executive branch has never issued regulations defining the
standards or procedures that states must follow to win approval of proposed changes to the state
programs. 21 Instead, HHS has used a variety of informal, non-binding methods to communicate
procedures and rules for the program. HHS has, for example, published notices in the Federal
Register; issued operations manuals; and disseminated department letters approving state
programs, as well as letters to various state officials, researchers, and policymakers. 22
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For example, in September 1994, HHS published a public notice in the Federal Register
announcing that the Clinton Administration would interpret section 1115 waiver authority
broadly. 23 One of the most significant aspects of the public notice was its endorsement of
demonstration programs that lasted longer than five years. This meant that the duration of an
experimental project was no longer an important factor in determining whether it would win
federal approval. 24 In addition, the costs of a demonstration project would be evaluated across
the project’s lifespan rather than on an annual basis. 25 Finally, the Administration allowed states
to redirect monies from other parts of their Medicaid programs to demonstration projects.
After the Clinton Administration opened the door to massive changes in Medicaid through the
section 1115 waiver program, the Bush Administration embarked on an era of significantly
greater state flexibility. In August 2001, HHS Secretary Tommy Thompson announced the
creation of the Health Insurance Flexibility and Accountability (“HIFA”) initiative. 26 These
waivers provide an expedited review process for states requesting waiver authority to loosen
Medicaid requirements. In addition, HIFA’s provisions help make waivers more widely
available. 27
What started out as a fairly non-existent research and demonstration program in the 1960s has
burgeoned into a shadow federal entitlement program. The Congressional Research Service
(CRS) reports that as of January 2007, there have been 110 operational Medicaid and SCHIP
waivers granted under section 1115. 28 In FY2005, federal spending on these waivers totaled
$26.6 billion, accounting for nearly 15% of all federal Medicaid spending. 29 Even more
surprising, nearly 14 million Americans receive Medicaid coverage through a section 1115
waiver program.
States are taking enormous advantage of the waiver process. The Obama Administration must
decide whether it wishes to continue this approach. Some waiver programs have existed for
more than fifteen years: states appear to re-apply and receive approval for the same program
when nearing the expiration date. Numerous states have also created section 1115 waiver
programs that apply statewide: many states provide comprehensive benefits through these
programs instead of using them solely to test financing schemes or benefit packages. Several
states have also used waivers to create “me, too” programs that are carbon copies of programs in
other states. For example, a number of states have embraced the waiver program for providing
family planning coverage.
In addition, the Obama Administration could allow states to continue using waivers to forgo
some of the traditional requirements in Medicaid. States must ordinarily provide coverage to all
those in a particular group who are eligible. 30 Medicaid unequivocally forbids enrollment caps,
even when state budgets may not be able to cover everyone who is eligible. Despite this
requirement, previous administrations have approved state waiver programs that cap the number
of beneficiaries covered. Some states have also used waivers to create significant variation in the
program design or benefits packages across the state, even though under the traditional Medicaid
program these packages must be uniform for all participants. Many states are also providing
different benefits packages to different groups of beneficiaries under the waiver programs,
disregarding Medicaid’s mandate that all persons eligible for health care coverage must receive a
uniform benefits package. 31
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The evolution of section 1115 reveals the significant executive authority available to President
Obama to make changes to Medicaid and SCHIP. There are numerous opportunities for the new
Administration and Congress to experiment with many of the policy ideas that have been
proposed recently, including expanding eligibility, changing benefits packages, trying new
payment schemes, and encouraging coordinated care among physicians serving Medicaid
beneficiaries.
B. Test Quality Initiatives Through Medicare Demonstration Authority
President Obama, John McCain, and a number of legislators have recommended changes to the
Medicare program. Senator McCain, for example, suggested that Medicare modify its payment
scheme to base provider compensation on diagnosis, prevention, and care coordination. He also
proposed eliminating reimbursements for preventable medical errors and requiring disclosure of
medical outcomes, quality of care, and costs. President Obama has discussed plans to base
physician payment on performance, as well as to require the use of disease management
programs to help those suffering from chronic conditions.
Medicare provides a significant source of executive authority for the President to determine
whether these policies are worth pursuing on a larger scale. Little known and not often used,
demonstration authority under the Medicare program would allow the Obama Administration to
test new policies on a temporary basis. Section 222(a) of the Social Security Amendments of
1972 is the source of the executive’s waiver authority. 32 The Centers for Medicare and Medicaid
Services (CMS) may invoke this authority to “develop and engage in experiments and
demonstration projects” to accomplish a variety of goals, including experimenting with new
payment or reimbursement methods to increase program efficiency; testing policies that reduce
Medicare spending; and trying new contracting methods with providers. 33 In so doing, the
agency has extensive authority to forgo existing payment requirements for participants in the
demonstration projects, thereby raising the possibility of increased Medicare spending. 34 In
addition, the Secretary may waive compliance with other Medicare requirements as long as they
relate to payment or reimbursement. 35
Despite this significant grant of demonstration authority, previous administrations have not
invoked it often. Part of the reason may be that Congress usually authorizes the creation of
Medicare demonstration projects, as it did with the Medicare Modernization Act of 2003,
thereby limiting the need to rely solely on section 222 waivers. 36 Also, CMS has tended to
invoke its section 222 authority most often to create capitated payment schemes in
“Medicare/Medicaid integration projects for dual eligibles:” elderly and impoverished
beneficiaries who receive benefits from both entitlement programs. 37
There are currently about fifty existing demonstration projects that have been authorized by
section 222 waivers. 38 A review of these projects reveals that CMS is testing payment schemes
to accomplish a variety of goals, including paying doctors for their success (i.e., performance) in
satisfying clinical measures; 39 providing hospice services for beneficiaries living in rural areas; 40
expanding disease management and coordinated care; 41 and creating new programs that improve
the quality of care delivered, as mandated by section 646 of the 2003 Medicare drug bill. 42
Therefore, the Obama Administration could expand the use of its section 222 authority to test
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many, if not all, of the Medicare policies that the President proposed during the campaign. In
addition, Congress could pass legislation to encourage experimentation of quality and other
programs pursuant to the President’s section 222 power.
C. Expand Health Information Technology
Expanding the use of health information technology is a popular bipartisan policy that finds its
way into most legislative reform proposals. The potential benefits are three-fold: using health IT
could make the health care system more efficient, improve the quality of care delivered, and
reduce costs in the long-run. 43 Policymakers must resolve numerous issues in designing and
implementing health IT programs, including financing new computer systems, protecting patient
privacy, and creating common computer “languages” and standardizing codes so numerous
actors – doctors, hospitals, insurers, etc. – can exchange information effectively and efficiently. 44
This paper sets aside those difficult policy questions and addresses how the Obama
Administration could use existing sources of authority to expand upon the existing policies.
With numerous health IT programs already underway in the executive branch comes the
likelihood for confusion and duplication of efforts. For example, at least eight agencies or
organizations within HHS are currently involved in health IT efforts – including the American
Health Information Community, the Office of the National Coordinator for Health Information
Technology, the Federal Health Architecture, the Agency for Healthcare Research and Quality
(which provides approximately $170 million in technology grants and contracts), the Health
Resources and Services Administration, Indian Health Services, the National Institutes of Health,
and the Centers for Medicaid and Medicare Services. This does not include separate electronic
health record systems operated by the Department of Defense and the Veterans Health
Administration, or the many private sector initiatives being led by insurers and other non-profit
groups.
Even though the National Coordinator is partly responsible for coordinating executive branch
efforts, his primary responsibility is to develop a national infrastructure so a majority of
Americans have an electronic medical record by 2014. 45 Obtaining a comprehensive assessment
of all the various efforts, therefore, is necessary to know where authority lies and how Congress
can most effectively expand the President’s power to significantly ramp up health IT efforts.
The new administration could issue executive orders not only to direct agencies to complete a
comprehensive review by a certain date, but also to help coordinate the activities of various
agencies. 46
Additionally, as part of the Medicare physician payment legislation passed in July 2008, doctors
may receive reimbursement increases for participating in an electronic prescribing program in
Medicare Part D. 47 Even though the legislation sets the percentage increase in reimbursements,
CMS has significant authority to fill out the details of the program within the confines of the
statute. For example, CMS may determine the numerous rules that physicians must follow for
how and what kind of data (i.e., drug type, benefits, potential chemical interactions, availability
of alternatives) they should report -- rules that will significantly impact the number of
participants and overall success of the program. 48
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Although the Bush Administration has made progress in setting some of these standards
pursuant to authority provided in the Medicare Modernization Act (MMA), 49 which created
Medicare Part D, much more work is needed for implementing the new reimbursement
program. 50 The Administrator also may provide hardship exceptions for providers who have
difficulty satisfying the rules, including those in rural areas “without sufficient Internet
access.” 51 The new program, which was scheduled to begin on January 1, 2009, offers great
opportunities for the new administration to experiment with e-prescribing policies until the fiveyear sunset in 2013. 52 Therefore, the physician reimbursement program is a source of significant
authority to quickly expand the use of e-prescribing.
Finally, the new administration could rely on CMS’s extensive demonstration authority in the
Medicare program, as previously discussed, to experiment with reimbursement schemes that
base payment on the quality of care provided (i.e., performance) and the use of technology. A
recent demonstration project created by the Bush Administration provides a useful example. The
Electronic Health Records Demonstration attempts to expand the use of electronic health records
to help reduce both medical errors and costs. 53 CMS does not provide any up-front grants or
payments to help physicians install the necessary programs. 54 Instead, the program pays primary
care physicians who adopt electronic health records and then use them to provide data (which
indicates performance) on a number of clinical quality measures, including for chronic
conditions such as diabetes and heart disease. 55
There are three types of payments: an annual incentive payment lasting the duration of the fiveyear program; a payment after the second year for reporting the data; and a payment after each of
the remaining years for performance. 56 The program uses existing measures endorsed by the
National Quality Forum and used by health plans for years. 57 Such a program reflects the
breadth of opportunities available to President Obama to test various policies before seeking
congressional approval for health IT programs.
D. Promulgate Rules to Allow Drug Re-importation, As Well As Experiment With the
Secretary’s Contracting Power Under Medicare
Two important sources of executive authority provide potential opportunities for the new
administration to reduce federal drug spending. In 2003, Congress passed the MMA, 58 making
the biggest statutory change to the Medicare program since its enactment in 1965. The MMA
explicitly denies the Secretary the power to negotiate drug prices with manufacturers under Part
D 59 ; therefore, the Obama administration will not be able to negotiate drug prices unless
Congress amends section 1860D-11(i) of the MMA. However, the bill significantly expands the
regulatory power of the HHS Secretary to implement the new drug benefit. Yet the Secretary
has not taken full advantage of the congressional delegations of authority. Section 1121, in
particular, gives the Secretary the power to allow U.S. licensed pharmacists and prescription
drug wholesalers to re-import U.S. manufactured medications from Canada. 60 The statute
explicitly provides rulemaking authority to the Secretary to supply the details of the program
without returning to Congress for additional grants of authority.
Before moving forward, however, HHS must satisfy some threshold safety measures, including
certifying to Congress that the program “will pose no additional risk to the public’s health and
safety.” 61 In addition, importers must provide a host of information and promise to test reO’NEILL INSTITUTE FOR NATIONAL AND GLOBAL HEALTH LAW
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imported drugs. Finally, the Department may provide waivers to individuals wishing to reimport drugs, although statistics reveal that millions of Americans already purchase drugs from
other countries via the Internet. 62 Because the Bush Administration did not invoke section 1121
to create a Medicare drug re-importation program, President Obama will have an opportunity to
tap into this significant source of congressionally delegated power to help reduce Medicare drug
spending.
Certainly, the recent news about contaminated products from China give some pause regarding
the assurance of safety in a Medicare drug re-importation program. However, section 1121 only
allows re-importation from Canada and provides broad authority to the Secretary to set specific
safety guidelines before allowing foreign-made drugs to enter U.S. borders. This “safety
assurance” power is crucial for any steps the President wishes to take to place formal guidelines
on the drugs that individuals are bringing across U.S. borders.
Another source of potential executive power is section 911 of the MMA. 63 Dubbed “Increased
Flexibility in Medicare Administration,” the statute grants the Department authority to enter into
contracts with “providers of services, suppliers, and individuals” that administer the drug
benefit. 64 Private insurers and other entities will serve as and largely replace the financial
intermediaries that process the millions of claims they receive from providers each year.
The MMA’s contracting language may provide the Obama Administration opportunities to
invoke this authority to limit program costs. The legislative history notes that section 911
“would permit the Secretary to competitively contract with any eligible entity to serve as a
Medicare Administrative Contractor (MAC).” 65 These new groups, operated by CMS, wield
power to “mak[e] the payments” under Parts A and B of Medicare and to “determin[e] the
amount of Medicare payments required to be made to providers and suppliers.” 66 The legislative
history also conveys Congress’s blessing to allow the Secretary to develop measurements for
evaluating the MACs’ performance. Given the broad power delegated to CMS to negotiate
contracts and rely on competitive bidding, opportunities exist for the agency to help keep
Medicare spending down through free-market tools. It is important to note, however, that this
power is limited. The MMA constrains the executive’s authority such that the Secretary may not
use the authority to change drug prices or the delivery system under Part D. 67 MACs must make
payments pursuant to Title XVIII requirements. 68
Given the recent media attention regarding the amounts Medicare pays Durable Medical
Equipment (DME) manufacturers, there is significant concern about how the new administration
will continue to implement this contracting authority. As CMS finishes choosing and negotiating
with DME MACs and the contractors for Parts A and B, the terms that CMS sets in these
contracts at the early stages of the program will have an enormous impact on the level of costs
savings it can generate. 69
E. Enhance Patient Protections and Private Coverage Requirements
Both President Obama and Senator McCain offered campaign proposals to regulate the activities
of the insurance industry. These proposals can be divided into two groups generally: 1)
protecting patients’ rights and 2) ensuring affordable, portable coverage with fewer restrictions.
In the area of patients’ rights, President Obama could invoke his executive authority to shape the
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Federal Employees Health Benefits Plan (FEHBP) by ordering federal agencies to adopt
consumer protections in their health insurance policies. 70 President Clinton issued similar orders
that directed the federal Office of Personnel Management (OPM) to punish insurers - possibly by
terminating their contracts - when they did not comply with the requirements in his directives. 71
This order fulfilled two goals: it expanded patients’ rights for federal employees, and it laid the
groundwork for future legislation on managed care by creating a precedent of rules applicable to
a large, privately-insured group. 72
The Senate made its most significant push for a Patients’ Bill of Rights in 2001. Even though
the bill ultimately was not enacted, Senator McCain joined with Senator Edward Kennedy to
push legislation that demanded assurances of swift review and appeals processes for denial of
coverage; added requirements on HMOs to remove barriers to specialty and emergency care; and
provided enforcement mechanisms to ensure compliance by insurance companies. Despite its
failure, opportunities remain for the Obama Administration to memorialize and apply many of
these additional protections in the FEHBP through executive orders and memoranda. Given that
approximately 8 million people participate in the program, creating these policies in the FEHBP
would, at the very least, help policymakers understand what works before trying to enact these
protections for the privately insured population at large.
The second source of executive authority originates with the Kennedy-Kassebaum legislation
passed in 1996, also known as the Health Insurance Portability and Accountability Act
(HIPAA). 73 This legislation enacted new portability and continuity of coverage requirements
and requires insurers to offer individuals with pre-existing conditions the same access to benefits
as the general public. It does not, however, set price limits or guarantee affordability.
HIPAA explicitly gave the President rulemaking authority to implement various parts of the
bill. 74 The Clinton Administration invoked this power to issue an interim rule detailing the
portability requirements and other obligations imposed on insurers. This rule covered a host of
important policy issues, from defining the terms of enrollment to placing limitations on preexisting condition exclusions to determining when employers are not liable for treating
employees’ ailments. 75 The Departments of Treasury, Labor, and Health and Human Services
continued to invite comments on the regulation until the end of the Clinton Administration,
leaving it to the Bush Administration to finalize the guidelines pertaining to insurers. 76
On December 30, 2004, the three departments issued the final rule. 77 Comprising 81 pages in
the Federal Register, HHS billed the changes as “regulations [that] essentially adopt the interim
final rules issued by the three agencies in 1997, but include several significant modifications.” 78
A review of the current rule reveals that much of the contents of the interim rule remained; for
example, it emphasizes the “narrowness of permissible pre-existing condition exclusions.” 79 Yet
the current version made significant changes to the interim rule; for example, it allows insurers
more latitude to impose a pre-existing condition exclusion for genetic illnesses. 80 In addition,
the new rule changed the requirements for HMO affiliation periods – the time before HMO
coverage becomes effective when a plan is not required to provide benefits. HMOs can apply
differing affiliation periods as long as they do not violate the nondiscrimination provisions in
HIPAA. The language in the rule is broad enough, however, to allow insurers to potentially
restrict coverage arbitrarily among various beneficiaries.
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During the campaign, President Obama said that he would prohibit insurers from denying
coverage based on pre-existing conditions. 81 The new administration may choose to reexamine
the December 30, 2004, rule to determine whether it does enough to ensure continuous coverage
and portability, and to limit the situations in which insurers may exclude coverage for those
suffering from pre-existing conditions. Given the explicit rulemaking authority provided to the
President in HIPAA, 82 President Obama also has the opportunity to create greater protections
through additional regulations and possibly new executive directives for private plans that
provide coverage for federal employees. The source of authority and its bounds are clear. The
big question facing the Obama Administration is whether it wants to invoke this fairly broad
power to create more rules for how the insurance industry operates.
F. Lift Agency Directives Restricting Coverage Under SCHIP and Medicaid
The Bush Administration has issued a number of regulations that reduce Medicaid spending.
These new policies, among other things, allow higher premiums and co-payments for medical
care; 83 eliminate funding for school-based outreach and enrollment programs; 84 cut federal
funding for graduate medical education programs at teaching hospitals; 85 and limit the types of
children’s rehabilitative services (e.g., therapy for some developmental disabilities) that
Medicaid will cover. 86 Even though Congress has enacted moratoria on the vast majority of
these rules, they provide only a temporary suspension. The cost-sharing rule alone could reduce
state and federal spending by $2.5 billion. 87 The Congressional Budget Office estimates that the
rest of the regulations could eliminate more than $21 billion from the program, 88 much of which
may be absorbed by state and local governments. 89
If the Obama Administration wishes to reconsider and possibly rescind these regulations, it could
invoke its executive authority in a two-step process. First, President Obama could issue an
executive order temporarily suspending or postponing action on regulations until further study of
their impact. This would allow him time to determine whether previous rationales for the rules
coincide with the his policy objectives – much like presidents since Ronald Reagan have done –
and determine what modifications, if any, are necessary. 90 Second, HHS could change or
permanently rescind the rules by promulgating new ones—but such a step would take time.
HHS would need to follow the informal rulemaking requirements to ensure that no procedural
deficiencies could open the new rules to legal challenge. Courts tend to be less deferential to
agencies when reviewing regulatory changes created without a change in circumstances, as
explained in Part III.A.3. Therefore, if the new administration chooses this approach, it should
be careful to supply a reasoned analysis of why it believes the new agency interpretation is
necessary.
Perhaps the most assertive recent invocation of executive power in the health care context is the
Bush Administration’s August 17, 2007, SCHIP directive. CMS issued the directive in the form
of a letter to State Health Officials (SHO) limiting their discretion to set income eligibility caps
for families whose kids participate in the Children’s Health Insurance Program. 91 Before
covering children in families earning above 250% of the federal poverty limit (FPL), states must
1) prove that they have covered at least 95% of children below 200% of the FPL; 2) ensure that
private coverage of these children has not decreased by more than “two percentage points over
the five-year period”; 92 3) require a twelve-month waiting period for children coming off private
coverage; and 4) impose new cost-sharing requirements. 93
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Several states, including California, Kentucky, Oklahoma, and New York, have filed suit against
HHS, claiming that the department has violated the Social Security Act and subsequent
amendments that govern the Medicaid program. 94 The Government Accountability Office
(GAO) and Congressional Research Service (CRS) have issued separate reports questioning the
legality of the Bush Administration’s directive. 95 Even though several members of Congress
have drafted legislation to override it, the new administration has a few options at its disposal to
revoke the August 17, 2007, directive, as well as set new policy for the SCHIP program. In fact,
President Obama issued a Presidential Memorandum on February 4, 2009, requesting that the
Secretary of the Department of Health and Human Services immediately withdraw the August 17
letter and implement SCHIP without the requirements it imposed. 96 This memorandum
represents one of the first instances of President Obama’s using his executive authority to
influence health policy.
G. Build On the Federal Employees Health Benefits Program
President Obama and Senator McCain both proposed policies for ensuring access to group
coverage for those with pre-existing conditions who find it difficult to buy policies on the
individual market. One option that has been mentioned as a potential springboard is the Federal
Employees’ Health Benefits Program (FEHBP). This popular program covers approximately 8
million people, including members of Congress, making it the largest employer-sponsored health
insurance program in the country. 97 Beneficiaries may choose between fee-for-service plans and
HMOs, with 70% opting for the former. 98 FFS policies are experience-rated, meaning that
premiums are calculated based on “average service expenditures, administrative costs, and
profits.” 99 Unlike many other government programs, however, the statute governing FEHBP
gives the Office of Personnel Management (OPM) enormous discretion to run the program. 100
The statute grants OPM the power to negotiate benefits packages and premiums annually with
plans. 101 In addition, OPM has the authority to suggest ways for plans to contain costs as they
craft their proposals and premium requirements. 102
OPM has kept costs down compared to the other large purchasers103 by using two mechanisms to
compel competition among the dozens of participating insurers. First, the basic construct of
FEHBP forces plans to compete with one another on the benefits offered. Even though OPM
does not define a specific benefit package, it requires a core baseline of services that all plans
must provide. Every plan, therefore, can build its own benefit package to cater to the population
it hopes to attract. Second, the statute requires that premiums “reasonably and equitably” reflect
the cost of the benefit packages provided through FEHBP. 104 The statute grants OPM the
authority not only to adjust premiums, but also to place any remaining balances in the reserve
funds when they prove too high. 105
One option for President Obama is to invoke executive orders and memoranda to memorialize
many of OPM’s practices. Because it operates more like a private employer than a public
program, many of the cost-saving programs and other policies are not formally noted and
available for public distribution. Especially given that OPM negotiates annually with plans, the
shelf life for these ideas may be relatively short. President Obama could use executive tools to
formalize many of these “best practices” for private insurers participating in other federal
programs (i.e., Medicare, Medicaid, etc.). To ensure the broadest reach for these policies and to
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promote consistency across departments, the new administration should use directives such as
executive orders or memoranda, rather than departmental letters.
Another question is how much the Obama Administration could experiment with expanding the
FEHBP. During the campaign, the President proposed the creation of a new public plan, the
National Health Insurance Exchange, through which small businesses and individuals could
purchase insurance benefits similar to those offered in the FEHBP. 106 The statute provides no
discretion to the OPM to replicate or open the program to populations beyond federal employees,
their beneficiaries, and retirees. In order to allow others to participate in the program or a similar
one, either by paying 100% of their own coverage or some other cost-sharing scheme, Congress
would have to pass legislation. If the Obama Administration wishes to test a program that allows
non-federal employees to participate, it would have to seek statutory authority even for a
demonstration project that would apply to a limited group of people on a temporary basis. In
1999, for example, Congress passed legislation creating a 3-year demonstration project run
jointly by the Department of Defense and OPM for Tricare beneficiaries. 107 Once the President
receives the authority, the contracting and negotiating power in Chapter 89 provides enormous
opportunity to test various policies, accumulate information about what works and what does
not, and craft more thoughtful proposals for more permanent and broad-based changes.
H. Examples of Policies That Require Legislative Enactment
Even though a President has significant executive authority to make policy changes, his actions
must adhere to the statutory language provided by Congress. Some of the health reform ideas
proposed by President Obama and Senator McCain would require new legislation because the
U.S. Code either does not provide the President the necessary authority, or it limits his
discretion. This section identifies two areas that would require congressional action: tax
proposals and selling insurance across state lines. It also reminds us that the President’s
authority to reform health care is not boundless.
The majority of health reform plans include some adjustment or revision of federal tax laws.
Changing tax policies – by offering new tax credits, modifying the currently favorable treatment
of employer-sponsored insurance, or eliminating various rules – would require legislative action.
The Constitution places the power to lay taxes solely in the legislative branch. 108 Therefore, the
President may not initiate changes to the tax structure, though he may obviously encourage
Congress to do so.
During the campaign, Senator McCain offered a proposal to allow insurers to sell insurance
across state lines in hopes of increasing competition and offering consumers greater choice.
Such a move would require federal preemption legislation. States have been the traditional
regulators of health insurance, as Congress explicitly recognized in 1945. 109 Even though most
states have some similar basic standards, there is significant variation in many of their
requirements, including access rules and types of benefits required. 110 Since the 1974 enactment
of the Employee Retirement Income Security Act (ERISA), the federal government has become
increasingly involved in regulating the benefits health insurance companies offer under
employer-sponsored health plans. ERISA exempted private sector self-insured plans from state
regulation. In addition, the Consolidated Omnibus Budget Reconciliation Act (COBRA) of
1986, and the Health Insurance Portability and Accountability Act (HIPAA) of 1996, provided
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additional consumer protections applicable to all private insurers. Despite this “floor” of federal
rules, many insurance requirements still vary across states. Because insurers must comply with
the laws of every state in which they operate, Congress would have to pass legislation explicitly
preempting state regulatory authority. Specifically, federal legislation would be necessary to
allow insurers to forgo some of the state rules so they could sell the same product across state
lines. 111
III. Limitations on Executive Authority
There are numerous ways to reform health care through the administrative process. Yet the
bedrock system of checks and balances ensures that executive authority is not boundless. Even
though the executive branch has grown in size, political aggressiveness, and policy impact, there
are significant limitations on what President Obama can do without congressional approval.
Article II, Section 1 of the Constitution, the “Vesting Clause,” is the starting point for
understanding these constraints. It entrusts the authority to run the executive branch in one
individual – the President. 112 Even though there is significant academic debate about how much
power the President can exercise over the agencies (particularly the independent ones), 113 recent
administrations have shown that the President ultimately controls the policy and political agenda
for the executive branch. 114 In addition, the Constitution explicitly rests responsibility with the
President for implementing Congress’s legislative directives. Nevertheless, by dictating that the
President “take Care that the Laws be faithfully executed,” 115 the framers of the Constitution
reminded the nation that the President’s power to implement statutes is conditioned by the
requirement that he or she adhere to Congress’s intent as memorialized by the statutory
language.
From stage right enters the judiciary. Courts play a critical role in making sure that the President
does not overstep the interpretive power delegated by Congress and limited by the Constitution.
The federal courts referee where Congress’s directives end and the President’s discretion begins.
Indeed, during the last thirty years, the courts have imposed procedural and substantive
constraints that limit the ability of agencies to disregard the will of Congress. It is often difficult,
however, to reconcile legislative intent with the interpretive latitude provided to the President,
particularly because Congress often does not clearly articulate its intentions. This tension has
spawned thousands of pages of case law on the subject of judicial review.
This section explains and discusses these legal doctrines to help policymakers understand the
limitations of reforming health care through the administrative process. It also analyzes the
budgetary and political constraints on executive authority from both the legal and policy
perspectives. Because history is often the best guide, Part III ends by providing statistics and
examples of times when Congress has aggressively responded to the President’s use of
administrative tools.
A. Judicial Review of Administrative Tools
Chevron, Skidmore-Mead, State Farm, and Youngstown. These case names are commonplace
among lawyers because they provide the legal boundaries that limit the executive branch’s
authority. These cases also are critically important to health policymakers so they can determine
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whether their proposals that rely not on Congress, but on administrative tools, encroach on the
legislature’s power to make law and on the judiciary’s power to “say what the law is.” 116 The
goal of this section is to assess the state of the law for both the legal and non-legal audience in
the health policy community.
1. Chevron: Statutory Interpretation
We start with the iconic administrative law case, Chevron, which courts use to evaluate the
propriety of an agency’s interpretation of statutes. Trumpeted as one of the most important
public law cases of the twentieth century, the Chevron Court held that when legislative language
is ambiguous, courts should defer to an agency’s “reasonable” interpretations of the statutory
text. 117 The Supreme Court provided a now famous two-step inquiry. First, courts should
determine “whether Congress has directly spoken to the precise question at issue.” 118 If, in other
words, Congress’s intent is unambiguously clear, then the agency must follow Congress’s
directive. If, on the other hand, Congress has not spoken directly to the precise question at issue
(i.e., the statute is silent or ambiguous), it is for the federal courts to determine whether the
agency’s interpretation of the statute is reasonable. An agency’s construction of a statute will
stand – even if a court disagrees with it – as long as it is deemed reasonable. 119 The lesson for
the Obama Administration is that it must be mindful of not veering too far from the statutory
language when it implements provisions of the MMA and other laws.
The Supreme Court emphasized two reasons for its groundbreaking holding: agency expertise
and political accountability. In explaining its decision, the Court signaled that presidential
involvement in agency decision-making counseled for a strong form of deference:
While agencies are not directly accountable to the people, the Chief Executive is,
and it is entirely appropriate for this political branch of the Government to make
such policy choices—resolving the competing interests which Congress itself
either inadvertently did not resolve, or intentionally left to be resolved by the
agency charged with the administration of the statute in light of everyday
realities. 120
2. Skidmore-Mead: Sub-Regulatory Guidance
There are numerous situations, however, in which there is no indication that Congress intended
to delegate authority to the executive branch to interpret the statute through regulations and other
administrative tools that have the force of law. 121 Nevertheless, agencies often need to create
policies, such as through sub-regulatory guidance as described in Part I, to flesh out the details of
a program when notice and comment rulemaking is impractical. An example of such a situation
is CMS’s August 17, 2007, letter restricting SCHIP coverage, as discussed above. Agencies also
can rely on these vehicles for implementing day-to-day decisions in Medicare, Medicaid, and
other complex programs. The Supreme Court has held that in such circumstances, it will accord
a relatively weaker standard of deference to the agency that is “proportional to [the agency’s]
power to persuade.” 122 Known as Skidmore-Mead deference, this second standard provides
more rigorous review of agency action than Chevron does.
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An agency must prove three things: first, that its interpretation is thorough, logical, and accords
with expert views; second, that its interpretation follows from the agency’s earlier interpretations
of the statute; and third, that other sources of weight support the interpretation.123 In short, under
the Skidmore-Mead deference regime, the courts delve more deeply into the permissibility of an
agency’s interpretation of a statute than they do under Chevron. The Court recognized that the
executive branch must often make decisions that Congress could not have foreseen, and that the
agencies’ expertise warrants some deference. 124 Nevertheless, questions remain about the level
of deference certain forms of sub-regulatory guidance (e.g., publications on agency web pages)
should receive. Time and litigation will eventually provide the answers.
3. State Farm: Regulatory Changes
The Supreme Court has indicated, however, that courts should look carefully at changes to
existing regulations. “An agency’s view of what is in the public interest may change, either with
or without a change in circumstances. But an agency changing its course must supply a reasoned
analysis.” 125 Decided the same year as Chevron, the Court in State Farm communicated its
frustration with the Reagan Administration’s decision to rescind a safety rule for seatbelts
despite the lack of change in external circumstances other than the election of a new president.
Since then, the Supreme Court has acknowledged in a number of health care cases that courts
should limit the deference provided to agency interpretations that conflict with previously-held
views. 126
When a court reviews an agency’s decision to revoke or modify a regulation, it applies the
standard for reviewing challenges to new rules: a court may set aside a rule if it is “arbitrary and
capricious.” 127 Put more plainly, an agency must offer a rational explanation for its policy
change and show that it accounted for the relevant facts and factors. 128 Even though the standard
of review is the same for new and modified rules, satisfying this standard may be more difficult
when the data on which the agency relied has not changed. As the Court explained:
Normally, an agency rule would be arbitrary and capricious if the agency has
relied on factors which Congress has not intended it to consider, entirely failed to
consider an important aspect of the problem, offered an explanation for its
decision that runs counter to the evidence before the agency, or is so implausible
that it could not be ascribed to a difference in view or the product of agency
expertise. 129
State Farm review, therefore, is critically important for President Obama as he considers
regulatory changes. If the new administration chooses to overturn some of President Bush’s
Medicaid or other regulations, it must anchor its explanation in data and facts that reveal a
changed environment.
4. Youngstown: Executive Orders
Finally, a president often initiates policies through executive orders. One example is President
Clinton’s order requiring insurers to comply with patient protection requirements in the FEHBP.
The Supreme Court has created a particular standard of judicial review for determining when an
executive order has strayed beyond the President’s authority. In Youngstown Sheet & Tube Co.
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v. Sawyer, a seminal post-World War II case, the Supreme Court held that executive authority to
issue an order “must stem either from an act of Congress or from the Constitution itself.” 130
To help courts analyze the scope of presidential power, the Court provided a three-part
framework. 131 First, if the President has acted pursuant to express or implied statutory authority,
then his “authority is at its maximum” and is “supported by the strongest of presumptions and the
widest latitude of judicial interpretation.” 132 Second, if Congress has neither delegated nor
denied authority to the President, then he must rely “upon his own independent powers, but there
is a zone of twilight in which he and Congress may have concurrent authority, or in which its
distribution is uncertain.” 133 Finally, if the President’s order contradicts Congress’s “express or
implied will,” his authority is at its lowest ebb. 134 Courts will uphold an executive order in such
circumstances only when the President’s authority is based on a constitutional grant of exclusive
power. 135
B. Constraints Involving Appropriations
Appropriations constraints also may limit a president’s authority to act unilaterally. The key
question is how much latitude a president has to determine health care spending priorities once
Congress has made the requisite appropriations. The President and agency officials are obligated
to follow congressional directives in statutory text. But the executive branch usually makes the
vast majority of spending decisions pursuant to lump-sum appropriations by Congress.
The Supreme Court provided clear guidance on this issue in Lincoln v. Vigil. The Court held that
agency spending decisions of a lump-sum appropriation are unreviewable in court. 136 In laying
out its rationale for the ruling, the Court emphasized the importance of permitting flexibility and
deferring to agency expertise regarding the numerous policies and issues that must be balanced:
The allocation of funds from a lump-sum appropriation is [an] administrative
decision traditionally regarded as committed to agency discretion. After all, the
very point of a lump-sum appropriation is to give an agency the capacity to adapt
to changing circumstances and meet its statutory responsibilities in what it sees as
the most effective or desirable way. 137
The Supreme Court further noted that Congress could only use explicit statutory text to bind
agencies to particular spending decisions. “[I]ndicia in committee reports and other legislative
history as to how funds should or are expected to be spent do not establish any legal
requirements on the agency.” 138 Obviously, the President and his agency heads run political
risks by ignoring legislative history and other indications by Congress that convey how it wishes
the money to be spent. Refusing to follow these expressions, however, does not violate the law.
President Obama will soon need to decide how he wishes his agencies to treat such legislative
requests or suggestions. In early 2008, former President George W. Bush issued an executive
order directing agencies not “to commit, obligate, or expend funds for any earmark” in a nonstatutory source. 139 In so doing, former President Bush took the discretionary principles of
Lincoln v. Vigil one step further by ordering employees not to comply with earmark requests in
legislative reports, letters from Members of Congress, or any other materials other than the
explicit statutory text. 140 It is too early to tell what impact the executive order will have. One
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obvious consequence may be that Congress increases use of explicit funding restrictions in
appropriations legislation, including those involving health care programs. The order goes
against the longstanding tradition that agencies should at least consider congressional spending
requests in committee reports and joint explanatory statements prepared by conference
committees. 141 If President Obama retains the order, it is unlikely that a court will find it
unlawful, particularly given the Supreme Court’s significant deference in Lincoln to agency
spending decisions.
C. Legislative Constraints: Congressional Review Act
The final question is how Congress can limit a President’s executive authority to reform health
care. The starting point is Congress’s primary function – passing legislation. As discussed
above, a significant source of the President’s power comes from the authority that the legislative
branch delegates through statutory text. Because Congress has increasingly delegated extensive
power to flesh out the details of federal programs – which can be just as significant as the
authorization itself – presidents have been able to take unilateral action much more often,
particularly during the last thirty years. 142 Within this expanding sphere of power, presidents can
utilize the many administrative tools available to shape policy.
But delegation is mostly a positive concept; it focuses on the power granted rather than
limitations placed on authority. The flipside is the negative act. Specifically, how could
Congress undo the President’s use of executive authority? Congress may limit agencies’
discretion through a number of processes, including appropriations bills. Perhaps the most
significant tool available is the Congressional Review Act (CRA). 143 Enacted in 1996, the Act
requires agencies to submit all rules to Congress before they can take effect. It allows Congress
to pass a joint resolution disapproving of regulations issued by agencies, which the President
must sign before the resolution takes effect. 144 The CRA also provides expedited procedures for
Congress to consider and disapprove of rules. For most rules, Congress has 60 days from when
it receives the rule to start the joint resolution process. 145 Once Congress enacts the resolution,
“the agency may not reissue either that rule or any substantially similar one, except under
authority of a subsequently enacted law.” 146
The question then is: how often has Congress successfully reversed regulations and other
directives by the executive branch? Congress has overturned only one rule under the CRA -- a
Clinton Administration ergonomics regulation in 2001. That should be unsurprising: garnering
a two-thirds vote in each chamber to overturn a presidential directive (assuming the president has
vetoed Congress’s first attempt) is extraordinarily difficult. Anecdotal evidence reveals that
legislators from 1940 to 1970 were equally unsuccessful at stopping Presidents’ efforts to create
policy unilaterally. 147
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Conclusion
As the Obama Administration crafts key policy and reform proposals for the coming years,
health reform is a priority. The executive branch has the power to create, shape, and promote
policy, including in health care. This authority is replete with legal issues steeped in both
constitutional and statutory law, as well as the history of governing our nation. This paper
describes ways that the President can work within constitutional and statutory boundaries to
implement health reform.
While this paper does not purport to recommend particular uses of that executive authority, or to
take a position on whether executive authority should be used expansively or sparingly, it
analyzes the contours of the President’s executive authority, and applies it to policy proposals
identified by key players in the health reform debate. Specifically, this paper discusses
administrative strategies to: (1) expand Medicaid and the State Children’s Health Insurance
Program (SCHIP) coverage through section 1115 waivers; (2) test quality initiatives through
Medicare demonstration authority; (3) expand health information technology; (4) allow drug reimportation and experiment with contracting power under Medicare; (5) enhance patient
protections and private coverage requirements; (6) lift coverage restrictions on Medicaid and
SCHIP; and (7) build on the health insurance program for federal employees. While President
Obama has already taken steps toward implementing his agenda, more options are available to
achieve the Administration’s policy goals.
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